Regeneron’s Covid-19 antibody may help non-hospitalized patients recover faster, early data show
KRISTOFFER TRIPPLAAR/SIPA VIA AP
Experts caution more data from larger trials will be needed to know how potentially beneficial monoclonal antibodies are.
No hay comentarios:
Publicar un comentario